Back to results
US 5,436,134 AGranted
Cyclic-substituted unsymmetrical cyanine dyes
AssigneeMolecular Probes, Inc.
InventorsRichard P. Haugland, Stephen T. Yue, Paul J. Millard, Bruce L. Roth
Life of this patent
Estimating the term…
Abstract
The invention describes the preparation and use of fluorescent stains for nucleic acids derived from unsymmetrical cyanine dyes. In particular, the invention describes unsymmetrical cyanine dyes having a saturated or unsaturated cyclic substituent. The dyes of the invention possess superior fluorescent characteristics when complexed with nucleic acids, and have utility in any application which requires detection of nucleic acids. The presence of the cyclic substituent results in improved permeability in a wide range of living cells, resulting in improved detection of intracellular nucleic acids.
Claims54
A compound of the formula ##STR34## wherein:
- each R.sup.1 is independently H;
- or an alkyl group having from 1-6 carbons;
- or a trifiuoromethyl;
- or a halogen;
- or --OR.sup.8,-- SR.sup.8 or --(NR.sup.8 R.sup.9) where R.sup.8 and R.sup.9, which can be the same or different, are independently H;
- or alkyl groups having 1-6 carbons;
- or 1-2 allcyclic, heteroalicyclic, aromatic or heterouromatic nngs, containing 1-4 heteroatoms, wherein the hetero atoms are O, N or S;
- or R.sup.8 and R.sup.9 taken in combination are --(CH.sub.2).sub.2 --L--(CH.sub.2).sub.2 -- where L=a single bond, --O--, --CH.sub.2 --, or --NR.sub.10 --,where R.sup.10 is H or an alkyl group having 1-6 carbons;
- and t=1-4;
- R.sup.2 is an alkyl group having 1-6 carbons;
- X is O, S, Se or --NR.sup.15, where R.sup.15 is H or an alkyl group having 1-6 carbons;
- or X is CR.sup.16 R.sup.17 where R.sup.16 and R.sup.17, which may be the same or different, are independently alkyl groups having 1-6 carbons, or R.sup.16 and R.sup.17 taken in combination complete a five or six membered saturated ring;
- n=0, 1 or 2;
- Z.sup.- is a biologically compatible counterion;
- Q has the formula Q1 or Q2 ##STR35## wherein Y is --CR.sup.3 =CR.sup.4 --;
- p and m=0 or 1, such that p+m=t;
- R.sup.5 is an alkyl, alkenyl, polyalkenyl, alkynyl or polyailkynyl group having 1-6 carbons;
- or R.sup.5 is aa OMEGA;
- R.sup.3, R.sup.4, R.sup.6 and R.sup.7, which may be the same or dillSrent, are independently H;
- or an alkyl, alkenyl, polyalkenyl, alkynyl or polyatlcynyl group having 1-6 carbons;
- or a halogen;
- or --OH, --OR.sup.8, --SR.sup.8, --(NR.sup.8 R.sup.9);
- or --OSO.sub.2 R.sup.19 where R.sup.19 is alkyl having 1-6 carbons, or perfluoroalkyl having 1-6 carbons, or aryl;
- or an OMEGA;
- or R.sup.6 and R.sup.7, taken in combination are --(CH.sub.2).sub.v -- where v=3 or 4, or R.sup.6 and R.sup.7 form a fused aromatic ring according to formula Q2;
- R.sup.11, R.sup.12, R.sup.13, and R.sup.14, which may be the same or different, are independently H, or an alkyl, alkenyl, polyalkenyl, alkynyl or polyalkynyl group having 1-6 carbons;
- or a halogen;
- or an OMEGA;
- or --OH, --OR.sup.8, --SR.sup.8, or --(NR.sup.8 R.sup.9);
- OMEGA is a cyclohexyl, cyclohexenyl, morpholino, piperidinyl, naphthyl, phenyl, thienyl, benzothiazolyl, furanyl, oxazolyl, benzoxazolyl or pyridinyl that is unsubstituted or optionally substituted one or more times, independently, by halogen, alkyl, perfluoroalkyl, areinc, alkylamino, dialkylamino, alkoxy or carboxyalkyl, having 1-6 carbons, and that is attached as R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, or R.sup.14 by a single bond;
- such that at least one of R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, and R.sup.14, is an OMEGA, and, where more than one of R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, and R.sup.14 is an OMEGA, each OMEGA is optionally the same or different;
- and
- such that when O has the formula Q1, n=O.
30 more elements
A fluorescent complex comprising a nucleic acid and one or more dye molecules of the formula ##STR38## wherein:
- each R.sup.1 is independently H;
- or an alkyl group having from 1-6 carbons;
- or a trifluoromethyl;
- or a halogen;
- or --OR.sup.8, --SR.sup.8 or --(NR.sup.8 R.sup.9) where R.sup.8 and R.sup.9, which can be the same or different, are independently H;
- or alkyl groups having 1-6 carbons:
- or 1-2 aft cyclic, heteroalicyclic, aromatic or heteroaromatic rings, containing 1-4 heteroatoms, wherein the hetero atoms are O, N or S;
- or R.sup.8 and R.sup.9 taken in combination are --(CH.sub.2).sub.2 --L--(CH.sub.2).sub.2 -- where L=a single bond, --O--, --CH.sub.2 --, or --NR.sub.10 -- where R.sup.10 is H or an alkyl group having 1-6 carbons;
- and t=1-4;
- R.sup.2 is an alkyl group having 1-6 carbons;
- X is O, S, Se or NR.sup.15, where R.sup.15 is H or an alkyl group having 1-6 carbons;
- or X is CR.sup.16 R.sup.17 where R.sup.16 and R.sup.17, which may be the same or different, are independently alkyl groups having 1-6 carbons, or R.sup.16 and R.sup.17 taken in combination complete a five or six membered saturated ring;
- n=0, 1 or 2;
- Z.sup.- is a biologically compatible counter ion;
- Q has the formula Q1 or Q2 ##STR39## wherein Y is --CR.sup.3 .dbd.CR.sup.4 --;
- p and m=0 or 1, such that p+m=1;
- R.sup.5 is an alkyl, alkenyl, polyalkenyl, alkynyl or polyalkynyl group having 1-6 carbons;
- or R.sup.5 is an OMEGA;
- R.sup.3, R.sup.4, R.sup.6 and R.sup.7, which may be the same or different, are independently H;
- or an alkyl, alkenyl, polyalkenyl, alkynyl or polyalkynyl group having 1-6 carbons;
- or a halogen;
- or --OH, --OR.sup.8, --SR.sup.8, --(NR.sup.8 R.sup.9);
- or --OSO.sub.2 R.sup.19 where R.sup.19 is alkyl having 1-6 carbons, or perfluoroalkyl having 1-6 carbons, or aryl;
- or an OMEGA;
- or R.sup.6 and R.sup.7, taken in combination are --(CH.sub.2).sub.v -- where v=3 or 4, or R.sup.6 and R.sup.7 form a fused aromatic ring according to formula Q2;
- R.sup.11, R.sup.12, R.sup.13, and R.sup.14, which may be the same or different, are independently H;
- or an alkyl, alkenyl, polyalkenyl, alkynyl or polyalkynyl group having 1-6 carbons;
- or a halogen;
- or an OMEGA;
- or --OH, --OR.sup.8, --SR.sup.8, or --(NR.sup.8 R.sup.9);
- OMEGA is a saturated or unsaturated, substituted or unsubstituted, cyclic substituent that has a total of 2-16 ring carbon atoms in 1-2 alicyclic, heteroalicyclic, aromatic, or heteroaromatic rings, containing 1-4 heteroatoms wherein the hetero atoms are O, N or S, that is unsubstituted or optionally substituted one or more times, independently, by halogen, alkyl, perfluoroalkyl, alkoxy or carboxyalkyl, having 1-6 carbons, and that is attached as R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, or R.sup.14 by a single bond;
- such that at least one of R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, and R.sup.14 is an OMEGA, and, where more than one of R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, and R.sup.14 is an OMEGA, each OMEGA is optionally the same or different.
29 more elements
A method of staining nucleic acids in a sample, comprising
- a) combining a sample that contains nucleic acids with a dye compound of the formula:
- ##STR42## wherein:
- each R.sup.1 is independently H;
- or an alkyl group having from 1-6 carbons;
- or a trifluoromethyl;
- or a halogen;
- or --OR.sup.8, --SR.sup.8 or --(NR.sup.8 R.sup.9) where R.sup.8 and R.sup.9, which can be the same or different, are independently H;
- alkyl groups having 1-6 carbons;
- or 1-2 alicyclic, heteroalicyclic, aromatic or heteroaromatic rings, containing 1-4 heteroatoms, wherein the hetero atoms are O, N or S;
- or R.sup.8 and R.sup.9 taken in combination are --(CH.sub.2).sub.2 --L--(CH.sub.2).sub.2 -- where L=--O--, --NR.sub.10 ', --CH.sub.2 -- or a single bond where R.sup.10 is H or an alkyl group having 1-6 carbons;
- and t=1-4;
- R.sup.2 is an alkyl group having 1-6 carbons;
- X is O, S, Se or NR.sup.15, where R.sup.15 is H or an alkyl group having 1-6 carbons;
- or X is CR.sup.16 R.sup.17 where R.sup.16 and R.sup.17, which may be the same or different, are independently alkyl groups having 1-6 carbons, or R.sup.16 and R.sup.17 taken in combination complete a five or six membered saturated ring;
- n=0, 1 or2;
- Z.sup.- is a biologically compatible counter ion;
- Q has the ;formula Q1 or Q2 ##STR43## wherein Y is --CR.sup.3 .dbd.CR.sup.4 --;
- p and m=0 or 1, such that p+m=1;
- R.sup.5 is an alkyl, alkenyl, polyalkenyl, alkynyl or polyalkynyl group having 1-6 carbons;
- or R.sup.5 is an OMEGA;
- R.sup.3, R.sup.4, R.sup.6 and R.sup.7, which may be the same or different, are independently H;
- or an alkyl, alkenyl, polyalkenyl, alkynyl or polyalkynyl group having 1-6 carbons;
- or a halogen;
- or --OH, --OR.sup.8, --SR.sup.8, --(NR.sup.8 R.sup.9);
- or --OSO.sub.2 R.sup.19 where R.sup.19 is alkyl having 1-6 carbons, or perfluoroalkyl having 1-6 carbons or aryl;
- or an OMEGA;
- or R.sup.6 and R.sup.7, taken in combination are --(CH.sub.2).sub.v -- where v=3 or 4, or R.sup.6 and R.sup.7 form a fused aromatic ring according to formula Q2;
- R.sup.11, R.sup.12, R.sup.13, and R.sup.14, which may be the same or different, are independently H;
- or an alkyl, alkenyl, polyalkenyl, alkynyl or polyalkynyl group having 1-6 carbons;
- or a halogen;
- or an OMEGA:
- or --OH, --OR.sup.8, --SR.sup.8, or --(NR.sup.8 R.sup.9);
- OMEGA is a saturated or unsaturated substituted or unsubstituted, cyclic substituent that has a total of 3-16 ring carbon atoms in 1-2 alicyclic, heteroalicyclic, aromatic, or heteroaromatic rings, containing 1-4 heteroatoms wherein the hetero atoms are O, N or S, that is unsubstituted or optionally substituted by halogen, alkyl, perfluoroalkyl, amino, alkylamino, dialkylamino, alkoxy or carboxyalkyl, having 1-16 carbons, and that is attached as R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, or R.sup.14 by a single bond;
- such that at least one of R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, and R.sup.14 is an OMEGA, and, where more than one of R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.11, R.sup.12, R.sup.13, and R.sup.14 is an OMEGA, each OMEGA is optionally the same or different.
- b) incubating the sample for a time sufficient for the dye compound to combine with the nucleic acid in the sample to form a nucleic acid-dye complex that gives a detectable fluorescent signal;
- c) observing the detectable fluorescent signal of the nucleic acid-dye complex.
33 more elements
A pyridinium or quinolinium salt of the formula:
- ##STR46## or of the formula:
- ##STR47## wherein R.sup.5 is an OMEGA;
- B is methyl;
- R.sup.6 and R.sup.7 are H:
- R.sup.3, R.sup.11, R.sup.12, R.sup.13, and R.sup.14 are independently H or alkyl having 1-6 carbons
- R.sup.4 is F, Cl, Br, I, or --OSO.sub.2 R.sup.19 where R.sup.19 is alkyl having 1-6 carbons, or perfluoroalkyl having 1-6 carbons, or aryl.
3 more elements
A cyclic-substituted unsymmetrical cyanine dye, comprising a first heterocyclic ring system that is a substituted benzothiazolium, benzoxazolium, benzoselenazolium, benzimidazolium, or dialkylindolinium;
- That is linked by a monomethine, trimethine, or pentamethine bridging moiety attached at the 2-position of said first ring system to the 2- or 4- position of a second heterocyclic ring system that is a substituted quinolinium or that is linked by a monomethine bridging moiety attached to the 2-position of a second heterocyclic ring system that is a substituted pyridinium;
- wherein one or more substituents of said second ring system is an OMEGA, where OMEGA is a substituted or unsubstituted cyclohexyl, cyclohexenyl, morpholino, piperidinyl, naphthyl, phenyl, thienyl, benzothizolyl, furanyl, oxazolyl, benzoxazolyl or pyridinyl.
Dependencies are inferred from the claim text.